טוען...
A product of independent beta probabilities dose escalation design for dual-agent phase I trials
Dual-agent trials are now increasingly common in oncology research, and many proposed dose-escalation designs are available in the statistical literature. Despite this, the translation from statistical design to practical application is slow, as has been highlighted in single-agent phase I trials, w...
שמור ב:
| הוצא לאור ב: | Stat Med |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Blackwell Publishing Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4409822/ https://ncbi.nlm.nih.gov/pubmed/25630638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6434 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|